Atlas Trials

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Clinical trial NCT03368651 · RECRUITING

Trial details

NCT number
NCT03368651
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2016-01-01
Primary completion
2026-11-30
Enrollment
230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.